# Gastric Functions & Proton Pump Inhibitor( PPI) Study

> **NCT00951431** · PHASE4 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 155 (actual)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00951431
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12-03
- **Primary completion:** 2015-12-31
- **Final completion:** 2016-02-19
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2019-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00951431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00951431, "Gastric Functions & Proton Pump Inhibitor( PPI) Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00951431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*